Search details
1.
Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine.
PLoS Med
; 13(12): e1002136, 2016 Dec.
Article
in English
| MEDLINE | ID: mdl-27923043
2.
Survival and prognostic factors of stage I-III breast cancer.
J Med Assoc Thai
; 96 Suppl 3: S23-34, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-23682519
3.
Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer-Results from Phase Ib Trial IMU.ACS.001.
Clin Cancer Res
; 27(13): 3649-3660, 2021 07 01.
Article
in English
| MEDLINE | ID: mdl-33879458
4.
Prognostic factors for survival in colorectal cancer patients.
J Med Assoc Thai
; 93(10): 1156-66, 2010 Oct.
Article
in English
| MEDLINE | ID: mdl-20973318
5.
Open-label, phase IIa study of dabrafenib plus trametinib in East Asian patients with advanced BRAF V600-mutant cutaneous melanoma.
Eur J Cancer
; 135: 31-38, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32534242
6.
A randomized, double-blind, placebo-controlled study evaluating the efficacy of combination olanzapine, ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving doxorubicin plus cyclophosphamide.
Ann Palliat Med
; 8(4): 372-380, 2019 Sep.
Article
in English
| MEDLINE | ID: mdl-31500422
7.
Prognostic factors for survival in advanced non-small cell lung cancer.
J Med Assoc Thai
; 87(9): 1056-64, 2004 Sep.
Article
in English
| MEDLINE | ID: mdl-15516006
Results
1 -
7
de 7
1
Next >
>>